Who we are
Antimicrobial Resistance (AMR) is a threat to life and healthcare globally. The Antimicrobial Resistance Centre at the London School of Hygiene and Tropical Medicine (LSHTM) operates as a centre of excellence in AMR research. Bringing together researchers from a unique breadth of disciplines across the sciences and humanities, the Centre is known for its high quality disciplinary and interdisciplinary work to meet the complex challenge of AMR.
AMR Centre members have expertise in addressing drug-resistant infections along the whole research pipeline, including basic biology, genomics, pharmacology, clinical research, epidemiology, policy research, social sciences and modelling. Our expertise, established over decades of world-leading research in infectious diseases around the globe, lies in descriptive, experimental and translational research to understand and respond to AMR.
What we do
The Centre has unrivalled reach across scientists, policy makers and practitioners around the globe, with current AMR research in 30 countries. In our research we aim to:
- Describe where, how and why AMR is a problem
- Develop, model, evaluate and translate innovative solutions to reduce the threat of AMR.
Within the London School, there is a strong emphasis on the One Health paradigm, integrating research on human, animal and ecosystem health. This is crucial for tackling AMR, given that transmission and spread occurs through the movement of both microbes and antimicrobials between humans, animals and the environment.
As part of our commitment to world-leading research, we help to share and expand knowledge and foster new collaborations by: hosting seminars with speakers at the cutting-edge of their fields; organising and collaborating in events at LSHTM and across the world; actively engaging in debates on policy fortnightly academic-led newsletter and twitter feed.